Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Conklin Company, Inc.
EIR
•Conklin Company, Inc.•July 24, 2013

Conklin Company, Inc. – FDA EIR, Jul 24, 2013

Record Details

An FDA follow-up inspection was conducted at Conklin Company, Inc. in Shakopee, MN, from July 16 to July 24, 2013. This inspection aimed to verify the corrective actions implemented by the company following an October 2012 inspection, which had revealed significant Current Good Manufacturing Practice (cGMP) deficiencies for drug and dietary supplement products, alongside issues with misbranded dietary supplements, resulting in an eleven-item FDA-483. During this recent inspection, Conklin Company demonstrated substantial progress in addressing all previously identified violations. The company ceased production and destroyed its Fortress Defensive Skin Cream OTC drug product. They established new written procedures for verifying finished product specifications using third-party laboratories, managing customer complaints, defining probiotic product specifications, and governing product holding and distribution operations. Additionally, the company eliminated expiration dates, opting instead for manufacture dates, and outsourced all labeling operations to contract manufacturers. No new FDA-483 was issued during this inspection, signifying successful remediation of the prior deficiencies. However, three verbal recommendations were made and accepted by the company. These included enhancing procedures for finished product testing by detailing specific analyses and laboratories, clarifying timeframes and reporting responsibilities within the complaint handling process, and providing more specifics on product receipt, quarantine, release, and carrier details in the distribution procedures. This indicates the firm's commitment to compliance with regulatory standards.

Company
Conklin Company, Inc.
Inspection date
July 24, 2013
Product type
drugs
Office
Minneapolis District Office
People
  • Ivan E. Reyes
  • Earl Krueger (company_representative)
  • James M. Hysong (recipient)
View Company Profile

ID · 4410a0d4-09d0-4644-9c1c-3391801819ad

Other documents for Conklin Company, Inc.
  • EIR - 2017-05-10May 10, 2017
  • EIR - 2015-05-28May 28, 2015
  • EIR - 2012-10-24October 24, 2012
  • EIR - 2012-05-23May 23, 2012

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Conklin Company, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.